Published in J Neural Transm (Vienna) on May 20, 2011
Target identification for stereotactic thalamotomy using diffusion tractography. PLoS One (2012) 0.77
Deep brain stimulation in critical care conditions. J Neural Transm (Vienna) (2013) 0.76
Movement Disorders Following Cerebrovascular Lesions: Etiology, Treatment Options and Prognosis. J Mov Disord (2016) 0.75
Deep brain stimulation for the treatment of uncommon tremor syndromes. Expert Rev Neurother (2016) 0.75
Meta-Analysis of the Relationship between Deep Brain Stimulation in Patients with Parkinson's Disease and Performance in Evaluation Tests for Executive Brain Functions. Parkinsons Dis (2017) 0.75
Morphological and chemical analysis of a deep brain stimulation electrode explanted from a dystonic patient. J Neural Transm (Vienna) (2013) 0.75
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (2003) 6.59
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol (2009) 4.22
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet (1991) 3.89
Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med (2005) 3.88
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol (2005) 3.78
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Translational principles of deep brain stimulation. Nat Rev Neurosci (2007) 3.10
Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg (1992) 3.01
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord (1999) 2.98
A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med (2000) 2.92
Classification of dystonia. Adv Neurol (1998) 2.75
Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med (2006) 2.26
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain (2000) 2.25
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 2.08
Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain (2006) 2.07
Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry (2007) 2.03
Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg (2006) 2.02
Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg (2003) 2.01
The pathophysiology of tremor. Muscle Nerve (2001) 1.76
Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain (2010) 1.66
Deep brain stimulation for Parkinson's disease. Neurotherapeutics (2008) 1.53
Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg (2002) 1.51
Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci (1993) 1.51
Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry (1999) 1.49
Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr Scand (1960) 1.47
[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39
Physiological observations in stereotaxic operations in extrapyramidal motor disturbances. Brain (1960) 1.38
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol (1997) 1.36
Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord (2001) 1.36
Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery (1994) 1.35
Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord (2007) 1.33
Some certainty for the "zone of uncertainty"? Exploring the function of the zona incerta. Neuroscience (2005) 1.31
Electrical stimulation of the hippocampal epileptic foci for seizure control: a double-blind, long-term follow-up study. Epilepsia (2007) 1.21
Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet (2000) 1.19
Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg (2003) 1.16
Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology (2011) 1.16
Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord (2005) 1.13
Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology (2002) 1.13
Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry (2007) 1.12
Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology (1998) 1.11
Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery (1997) 1.11
Deep brain stimulation of the nucleus ventralis intermedius for Holmes (rubral) tremor and associated dystonia caused by upper brainstem lesions. Report of two cases. J Neurosurg (2004) 1.06
Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia. Lancet (1999) 1.06
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord (2009) 1.05
Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord (2008) 1.03
Electrical stimulation of the brain in treatment of chronic pain. Experience over 5 years. J Neurosurg (1985) 1.02
Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat Disord (2005) 1.02
Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature. Neurosurgery (1987) 1.02
Ventralis intermedius plus ventralis oralis anterior and posterior deep brain stimulation for posttraumatic Holmes tremor: two leads may be better than one: technical note. Neurosurgery (2005) 1.01
Center median-parafascicular complex and pain control. Review from a neurosurgical perspective. Stereotact Funct Neurosurg (2004) 1.00
Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain (2003) 1.00
Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. J Neurosurg (1999) 0.99
A case of posttraumatic tremor treated by chronic stimulation of the thalamus. Mov Disord (1993) 0.98
Reversal of thalamic hand syndrome by long-term motor cortex stimulation. J Neurosurg (2000) 0.97
Electrical stimulation of the centromedian thalamic nucleus in control of seizures: long-term studies. Epilepsia (1995) 0.97
Afferent connections of the zona incerta: a horseradish peroxidase study in the rat. Neuroscience (1985) 0.96
Enkephalin-like material elevated in ventricular cerebrospinal fluid of pain patients after analgetic focal stimulation. Science (1978) 0.95
Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg (2007) 0.93
Two-year follow-up of chronic stimulation of the posterior subthalamic white matter for tremor-dominant Parkinson's disease. Neurosurgery (2005) 0.92
Reversibility of chronic neurologic deficits. Some effects of electrical stimulation of the thalamus and internal capsule in man. Appl Neurophysiol (1980) 0.92
Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J Neurol Neurosurg Psychiatry (1999) 0.92
The neurons of the substantia nigra and zona incerta which project to the cat superior colliculus are GABA immunoreactive: a double-label study using GABA immunocytochemistry and lectin retrograde transport. Neuroscience (1989) 0.91
Deep brain stimulation for treatment of the epilepsies: the centromedian thalamic target. Acta Neurochir Suppl (2007) 0.91
Electrical stimulation of the prelemniscal radiation in the treatment of Parkinson's disease: an old target revised with new techniques. Neurosurgery (2001) 0.91
Thalamotomy versus thalamic stimulation for multiple sclerosis tremor. J Clin Neurosci (2005) 0.90
Stereotaxic interventions on the zona incerta area for treatment of extrapyramidal motor disturbances and their results. Confin Neurol (1965) 0.90
Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation. Mov Disord (1996) 0.90
Deep brain stimulation electrode used for radiofrequency lesion of the globus pallidus internus in dystonia. Stereotact Funct Neurosurg (2009) 0.90
Development of direct GABAergic projections from the zona incerta to the somatosensory cortex of the rat. Neuroscience (1995) 0.88
Benefits and risks of pharmacological treatments for essential tremor. Drug Saf (2003) 0.88
Bilateral Implantation of Centromedian-Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease. Neuromodulation (2006) 0.87
Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia. Report of two cases. J Neurosurg (2005) 0.87
Method of electrostimulation of the deep brain structures in treatment of some chronic diseases. Confin Neurol (1975) 0.86
[Treatment of early-onset generalized dystonia by chronic bilateral stimulation of the internal globus pallidus. Apropos of a case]. Neurochirurgie (1999) 0.86
Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry (2004) 0.86
[Treatment of Parkinson tremor by chronic stimulation of the ventral intermediate nucleus of the thalamus]. Rev Neurol (Paris) (1989) 0.85
The role of neuromodulation of the hippocampus in the treatment of intractable complex partial seizures of the temporal lobe. Acta Neurochir Suppl (2007) 0.85
Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl (2007) 0.84
Afferents to the zona incerta in the rat: a combined retrograde and anterograde study. J Comp Neurol (1985) 0.84
Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord (2007) 0.84
Thalamic stimulation for neuropathic pain. J Neurosurg (1980) 0.83
Stimulation of internal capsule for relief of chronic pain. J Neurosurg (1974) 0.83
Chronic motor cortex stimulation for movement disorders: a promising perspective. Neurol Res (2003) 0.82
Chronic cerebellar stimulation (CCS) and deep brain stimulation (DBS) in involuntary movement disorders. Appl Neurophysiol (1982) 0.81
Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg (2005) 0.81
Pain after cortical injury relieved by electrical stimulation of the internal capsule. Brain (1974) 0.81
Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. J Neurol (2009) 0.80
The organisation of the efferent projections of the zona incerta. J Anat (1985) 0.80
Deep brain stimulation of two unconventional targets in refractory non-resectable epilepsy. Stereotact Funct Neurosurg (2008) 0.79
Electrophysiological evidence that the mediodorsal nucleus of the thalamus is a relay between the ventral pallidum and the medial prefrontal cortex in the rat. Brain Res (1985) 0.79
Antiparkinsonian therapy modifications in PD patients after STN DBS: a retrospective observational analysis. Parkinsonism Relat Disord (2008) 0.78
Vim thalamotomy for the relief of the intention tremor of multiple sclerosis. Br J Neurosurg (1998) 0.78
Electrical stimulation of the posterior limb of the internal capsule for treatment of thalamic pain. Appl Neurophysiol (1984) 0.78
Chronic thalamic and internal capsule stimulation for the control of central pain. Surg Neurol (1975) 0.78
Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode. Mov Disord (2008) 0.78
Long-term chronic stimulation of internal capsule in poststroke pain and spasticity. Case report, long-term results and review of the literature. Stereotact Funct Neurosurg (2008) 0.78
Centro-median stimulation yields additional seizure frequency and attention improvement in patients previously submitted to callosotomy. Seizure (2009) 0.77
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain (2013) 2.40
Spontaneous intracranial hypotension syndrome: a novel speculative physiopathological hypothesis and a novel patch method in a series of 28 consecutive patients. J Neurosurg (2010) 2.38
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. N Engl J Med (2016) 2.36
Transportin-SR2 imports HIV into the nucleus. Curr Biol (2008) 2.35
PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol (2004) 2.30
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Electrophysiol (2008) 1.98
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol (2008) 1.96
Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol (2006) 1.86
Red flags for multiple system atrophy. Mov Disord (2008) 1.75
Is fluorescein-guided technique able to help in resection of high-grade gliomas? Neurosurg Focus (2014) 1.74
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet (2005) 1.71
PARK6-linked parkinsonism occurs in several European families. Ann Neurol (2002) 1.68
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain (2010) 1.66
Surgical site infections after elective neurosurgery: a survey of 1747 patients. Neurosurgery (2008) 1.66
Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery (2002) 1.65
Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain (2008) 1.63
Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol (2011) 1.62
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol (2007) 1.59
Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology (2009) 1.56
Image-guided endoscopic transnasal removal of recurrent pituitary adenomas. Neurosurgery (2002) 1.55
A novel impermeable adhesive membrane to reinforce dural closure: a preliminary retrospective study on 119 consecutive high-risk patients. World Neurosurg (2011) 1.53
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort. Dev Med Child Neurol (2011) 1.53
Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1. Intensive Care Med (2006) 1.53
Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Ann Neurol (2004) 1.51
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol (2002) 1.51
A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol (2003) 1.49
Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma. Haematologica (2002) 1.49
Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions. Mov Disord (2013) 1.45
Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery (2003) 1.41
Pallidotomy for medically refractory status dystonicus in childhood. Dev Med Child Neurol (2014) 1.40
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol (2012) 1.39
Paroxysmal non-epileptic motor events in childhood: a clinical and video-EEG-polymyographic study. Dev Med Child Neurol (2012) 1.39
Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease. Leuk Lymphoma (2011) 1.39
The role of indocyanine green videoangiography (ICGV) in surgery of parasagittal meningiomas. Acta Neurochir (Wien) (2013) 1.38
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord (2010) 1.34
Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases. Acta Neurochir (Wien) (2013) 1.34
Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma. J Neurooncol (2003) 1.30
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord (2002) 1.28
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon (2013) 1.27
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology (2003) 1.23
Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology (2008) 1.23
CD133 is essential for glioblastoma stem cell maintenance. Stem Cells (2013) 1.21
Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord (2011) 1.21
Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology (2006) 1.19
Meningiomas invading the superior sagittal sinus: surgical experience in 108 cases. Neurosurgery (2004) 1.19
Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res (2007) 1.19
Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord (2008) 1.15
Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord (2005) 1.13
Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations. Mol Genet Metab (2011) 1.13
Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11
Mutation screening of the DYT6/THAP1 gene in Italy. Mov Disord (2009) 1.11
Dendrimer internalization and intracellular trafficking in living cells. Mol Pharm (2010) 1.11
The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord (2010) 1.10
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord (2008) 1.06
Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Mol Cancer (2004) 1.06
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci (2012) 1.06
Neuritis ossificans. J Neurosurg (2014) 1.06
Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus: an Italian multicenter study. Neurosurgery (2008) 1.06
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum Mutat (2008) 1.06
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord (2009) 1.06
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord (2009) 1.05
Synergistic control of protein kinase Cgamma activity by ionotropic and metabotropic glutamate receptor inputs in hippocampal neurons. J Neurosci (2006) 1.01
Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol (2005) 1.01
Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol (2012) 0.99
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon (2012) 0.98
Inclusion and exclusion criteria for DBS in dystonia. Mov Disord (2011) 0.97
Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol (2011) 0.97
Microvascular decompression for glossopharyngeal neuralgia: a long-term retrospectic review of the Milan-Bologna experience in 31 consecutive cases. Acta Neurochir (Wien) (2009) 0.97
Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease. Neurol Sci (2013) 0.97
Non-DYT1 early-onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature. Mov Disord (2006) 0.97
Analysis of blink rate in patients with blepharospasm. Mov Disord (2006) 0.97
Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients. Neurogenetics (2011) 0.97
Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery. Neurol Sci (2009) 0.97
CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol (2004) 0.97
Novel combretastatin analogues endowed with antitumor activity. J Med Chem (2006) 0.97
Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J Neurol Sci (2010) 0.96
Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients. J Neurooncol (2004) 0.96